| 1 | resistance | 24,997 |
| 2 | resistances | 241 |
| 3 | resistance-associated | 84 |
| 4 | drug-resistance | 56 |
| 5 | resistance-related | 24 |
| 6 | multiresistance | 19 |
| 7 | hypersusceptibility | 8 |
| 8 | resistence | 8 |
| 9 | sensitivity/resistance | 7 |
| 10 | resistance/sensitivity | 6 |
| 11 | secretion-sensitivity | 5 |
| 12 | relaxation/meditation | 4 |
| 13 | cross-sensitivity | 3 |
| 14 | impedence | 3 |
| 15 | quinolone-resistance | 3 |
| 16 | resistance-1 | 3 |
| 17 | auc60 | 2 |
| 18 | bio-herbicides | 2 |
| 19 | resistance/metabolic | 2 |
| 20 | ros-eliminating | 2 |
| 21 | systems-related | 2 |
| 22 | technical-tactical | 2 |
| 23 | decoder | 1 |
| 24 | disease-home | 1 |
| 25 | disease-supervised | 1 |
| 26 | ezetimide | 1 |
| 27 | guidelines-staff | 1 |
| 28 | hif-activity | 1 |
| 29 | initiation/titration | 1 |
| 30 | invasion/extrahepatic | 1 |
| 31 | multiset | 1 |
| 32 | nephropa-thies | 1 |
| 33 | o2-supply | 1 |
| 34 | re-events | 1 |
| 35 | resistance-and | 1 |
| 36 | resistance-dyslipidemic | 1 |
| 37 | resistance.considering | 1 |
| 38 | resistant-hyperinsulinemic | 1 |
| 39 | risk-as | 1 |
| 40 | secretion/sensitivity | 1 |
| 1 | auc60 | 2 |
| 2 | bio-herbicides | 2 |
| 3 | cross-sensitivity | 3 |
| 4 | decoder | 1 |
| 5 | disease-home | 1 |
| 6 | disease-supervised | 1 |
| 7 | drug-resistance | 56 |
| 8 | ezetimide | 1 |
| 9 | guidelines-staff | 1 |
| 10 | hif-activity | 1 |
| 11 | hypersusceptibility | 8 |
| 12 | impedence | 3 |
| 13 | initiation/titration | 1 |
| 14 | invasion/extrahepatic | 1 |
| 15 | multiresistance | 19 |
| 16 | multiset | 1 |
| 17 | nephropa-thies | 1 |
| 18 | o2-supply | 1 |
| 19 | quinolone-resistance | 3 |
| 20 | re-events | 1 |
| 21 | relaxation/meditation | 4 |
| 22 | resistance | 24,997 |
| 23 | resistance-1 | 3 |
| 24 | resistance-and | 1 |
| 25 | resistance-associated | 84 |
| 26 | resistance-dyslipidemic | 1 |
| 27 | resistance-related | 24 |
| 28 | resistance.considering | 1 |
| 29 | resistance/metabolic | 2 |
| 30 | resistance/sensitivity | 6 |
| 31 | resistances | 241 |
| 32 | resistant-hyperinsulinemic | 1 |
| 33 | resistence | 8 |
| 34 | risk-as | 1 |
| 35 | ros-eliminating | 2 |
| 36 | secretion-sensitivity | 5 |
| 37 | secretion/sensitivity | 1 |
| 38 | sensitivity/resistance | 7 |
| 39 | systems-related | 2 |
| 40 | technical-tactical | 2 |
| 1 | auc60 | 2 |
| 2 | resistance-1 | 3 |
| 3 | resistance/metabolic | 2 |
| 4 | resistance-dyslipidemic | 1 |
| 5 | resistant-hyperinsulinemic | 1 |
| 6 | invasion/extrahepatic | 1 |
| 7 | disease-supervised | 1 |
| 8 | resistance-associated | 84 |
| 9 | resistance-related | 24 |
| 10 | systems-related | 2 |
| 11 | resistance-and | 1 |
| 12 | resistance | 24,997 |
| 13 | quinolone-resistance | 3 |
| 14 | drug-resistance | 56 |
| 15 | sensitivity/resistance | 7 |
| 16 | multiresistance | 19 |
| 17 | impedence | 3 |
| 18 | resistence | 8 |
| 19 | ezetimide | 1 |
| 20 | disease-home | 1 |
| 21 | guidelines-staff | 1 |
| 22 | resistance.considering | 1 |
| 23 | ros-eliminating | 2 |
| 24 | technical-tactical | 2 |
| 25 | initiation/titration | 1 |
| 26 | relaxation/meditation | 4 |
| 27 | decoder | 1 |
| 28 | risk-as | 1 |
| 29 | resistances | 241 |
| 30 | bio-herbicides | 2 |
| 31 | nephropa-thies | 1 |
| 32 | re-events | 1 |
| 33 | multiset | 1 |
| 34 | o2-supply | 1 |
| 35 | hypersusceptibility | 8 |
| 36 | hif-activity | 1 |
| 37 | secretion-sensitivity | 5 |
| 38 | cross-sensitivity | 3 |
| 39 | resistance/sensitivity | 6 |
| 40 | secretion/sensitivity | 1 |